- Home
- JCSE vs ICU Comparison
JCSE vs ICU Comparison
Compare JCSE & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- ICU
- Stock Information
- Founded
- JCSE 1999
- ICU 2018
- Country
- JCSE Singapore
- ICU United States
- Employees
- JCSE N/A
- ICU N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- ICU Health Care
- Exchange
- JCSE Nasdaq
- ICU Nasdaq
- Market Cap
- JCSE 7.6M
- ICU 10.4M
- IPO Year
- JCSE 2022
- ICU N/A
- Fundamental
- Price
- JCSE $1.68
- ICU $1.90
- Analyst Decision
- JCSE
- ICU
- Analyst Count
- JCSE 0
- ICU 0
- Target Price
- JCSE N/A
- ICU N/A
- AVG Volume (30 Days)
- JCSE 26.7K
- ICU 24.8K
- Earning Date
- JCSE 10-30-2024
- ICU 11-13-2024
- Dividend Yield
- JCSE 5.33%
- ICU N/A
- EPS Growth
- JCSE N/A
- ICU N/A
- EPS
- JCSE 0.12
- ICU N/A
- Revenue
- JCSE $14,723,999.00
- ICU $68,000.00
- Revenue This Year
- JCSE N/A
- ICU N/A
- Revenue Next Year
- JCSE N/A
- ICU $358.72
- P/E Ratio
- JCSE $13.69
- ICU N/A
- Revenue Growth
- JCSE N/A
- ICU N/A
- 52 Week Low
- JCSE $0.60
- ICU $1.50
- 52 Week High
- JCSE $2.39
- ICU $42.93
- Technical
- Relative Strength Index (RSI)
- JCSE 67.11
- ICU 64.59
- Support Level
- JCSE $1.43
- ICU $1.55
- Resistance Level
- JCSE $1.58
- ICU $1.78
- Average True Range (ATR)
- JCSE 0.08
- ICU 0.28
- MACD
- JCSE 0.03
- ICU 0.07
- Stochastic Oscillator
- JCSE 93.94
- ICU 50.00
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.